No Monetary Damages. So long as the Company has used its reasonable best efforts to comply with its registration-related obligations that are described in this Agreement, in no event will the Investor or any other Holder be entitled to receive any monetary damages or other damages from the Company (i) if the Registrable Securities are not registered with the Commission pursuant to an effective registration statement, (ii) if a current prospectus relating to the resale of the Registrable Securities is not on file with the Commission, or (iii) if the effectiveness of such registration statement is not maintained for the two-year period described in this Agreement.
Appears in 4 contracts
Samples: Securities Purchase Agreement (ImmunoCellular Therapeutics, Ltd.), Form of Registration Rights Agreement (ImmunoCellular Therapeutics, Ltd.), Securities Purchase Agreement (ImmunoCellular Therapeutics, Ltd.)
No Monetary Damages. So long as the Company has used its commercially reasonable best efforts to comply with its registration-related obligations that are described in this Agreement, in no event will the Investor or any other Holder be entitled to receive any monetary damages or other damages from the Company (i) if the Registrable Securities are not registered with the Commission pursuant to an effective registration statement, (ii) if a current prospectus relating to the resale of the Registrable Securities is not on file with the Commission, or (iii) if the effectiveness of such registration statement is not maintained for the two-year period described in this Agreement.
Appears in 1 contract
Samples: Registration Rights Agreement (ImmunoCellular Therapeutics, Ltd.)
No Monetary Damages. So long as the Company has used its commercially reasonable best efforts to comply with its registration-related obligations that are described in this AgreementAppendix I, in no event will the Investor or any other Holder be entitled to receive any monetary damages or other damages from the Company (i) if the Registrable Securities are not registered with the Commission pursuant to an effective registration statement, (ii) if a current prospectus relating to the resale of the Registrable Securities is not on file with the Commission, or (iii) if the effectiveness of such registration statement is not maintained for the two-year period described in this Agreement.Appendix I.
Appears in 1 contract
Samples: Subscription Agreement (ImmunoCellular Therapeutics, Ltd.)